Congresswoman Jahana Hayes (CT-5) announced today that Newtown resident Bridget Sclafani will join her as a guest to the State of the Union on February 4, 2020. Congresswoman Hayes met Bridget at a Congressional Update and was moved by her story and her courage to fight for families in similar circumstances. Bridget lost her husband, Paul, to brain cancer in 2018. During his treatment, they fought with insurance companies who denied services for his treatment and care. After Paul's passing, Bridget started a foundation in his honor to fund research and help other families battling cancer and dealing with insurance companies.
"No one should have to battle insurance companies while battling cancer," said Rep Hayes. "Bridget's strength and generosity to honor Paul's legacy by helping others, is an inspiration to us all. We must do more to ensure families like Bridget's can focus on their treatment without having to worry about the costs. Lower healthcare costs is something we can all agree on and I hope to hear the President talk about ways we can work together to help families like Bridget's across Connecticut."
"I was terrified when our insurance company denied the coverage my husband needed to keep him alive, and I swore I would do whatever I could to prevent other families from having to go through that terror," said Bridget. "I'm proud to join Congresswoman Hayes at the State of the Union to shine a light on the work that needs to be done to make sure all families have access to the care they need."
Hayes championed the Lower Drug Costs Now Act (H.R. 3), landmark legislation that would give Medicare the power to negotiate directly with drug companies, bring down prices and make those savings available to hardworking families across America.
Hayes also co-sponsored the CREATES Act, which was recently signed into law. The legislation makes it easier for generic drugs to come to market; saves taxpayer dollars; and helps lower prescription drug costs.
Congresswoman Hayes has also supported 11 other bills this Congress to lower drug costs, protect people with pre-existing conditions and increase coverage.